Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Catheter Precision, Inc Receives Additional Patents for LockeT in Great Britain and the European Market

Author: Benzinga Newsdesk | January 02, 2024 09:03am

Catheter Precision, Inc. (the "Company") (NYSE:VTAK), a US based innovative medical device company focused on electrophysiology products, announced today that Great Britain and the European Market have allowed two new patents (No. 6288592 and No. 015023977-0001), further strengthening the company's IP position for its LockeT product line. These new issued patents for LockeT are in addition to an issued patent in Japan earlier in 2023.

Posted In: VTAK


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist